Keebeck Wealth Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
Keebeck Wealth Management's CPRX Position: Q3 2026 in Review
Keebeck Wealth Management sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 10,763 shares — an estimated $338K sold.
Keebeck Wealth Management first reported a position in CPRX in Q1 2025 and held it in 6 quarters. The position peaked at $623K in Q1 2026. 3 funds tracked by Wall St. Rank hold CPRX as of Q3 2026.
- Keebeck Wealth Management reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
- Keebeck Wealth Management sold 10,763 Catalyst Pharmaceutical shares in Q3 2026, an estimated $338K.
- Keebeck Wealth Management first reported a position in Catalyst Pharmaceutical in Q1 2025 and held it in 6 quarters.
- Keebeck Wealth Management's Catalyst Pharmaceutical position peaked at $623K in Q1 2026.
- 3 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.
Based on Keebeck Wealth Management's 13F filing for Q3 2026, filed 12 Nov 2026.